7 Drugs Whose Dangerous Risks Emerged Only After Big Pharma Made Its Money

January 2, 2014  |

Have you ever noticed how warnings about dangerous prescription drugs always seem to surface after the drug is no longer marketed and its patent has run out? Whether it’s an FDA advisory or a trial lawyer solicitation about harm that may have been done to you, the warnings are always belated and useless. If a drug you took four years ago may have given you liver damage, why didn’t the FDA tell you then? Why didn’t the FDA recall the drug or better yet, not approve it in the first place?

The official answer from the FDA and Big Pharma is that problems with a drug are only seen after millions begin using it, which is why post-marketing surveillance is conducted. In other words—who knew? But in a startling number of cases revealed in court documents Pharma did“know” and clearly misled medical journals, the FDA, doctors and patients, hoping to get its patent’s worth before the true risks of a drug surfaced. In other cases, Pharma and the FDA should have known before rushing a dangerous drug to market and making money at the expense of patients. (more…)

Beware of Statins, Top Doctor Says

Statins, a class of cholesterol-lowering drugs, have recently made headlines for supposedly having other beneficial health effects. But are Lipitor, Torvast, Zocor, and other common statins really the wonder drugs that pharmaceutical companies seem to make them out to be? Newsmax Health contributor Dr. Erika Schwartz, one the nation’s top experts on aging and the author of four best-selling books, doesn’t think so. (more…)

Statin Drugs Side Effects and the Misguided War on Cholesterol

If you are on a statin drug or are thinking of going on a statin, this fully referenced book, Statin Drug Side Effects, is a “must read” for you.

The unacceptable legacy of statin drug use at today’s high doses is a trail of chronic aches and pains, numbness, weakness, confusion, fatigue, shortness of breath and even heart failure in hordes of unsuspecting victims.

Only by knowing this information, and in consultation with your healthcare professional, can you make an informed decision about your health care.

If you are a user of Vytorin, Lipitor, Zocor, Crestor, Mevacor, Pravachol or Lescol you must read this book. Most of the statin side effects I discuss are unknown to your busy doctor.

Although knowledgeable about muscle and liver problems, few have heard of statin amnesia and other forms of memory dysfunction and fewer still associate hostility, aggression and profound depression as statin related.

As a former astronaut, aerospace medical research scientist, flight surgeon and family doctor, I was appalled by the lack of information in the medical community on the full range of side effects of the statin drugs.

This book is a comprehensive reference source and summary of side effects of statin drugs.

Link here

Lipitor-Associated Memory Loss: Analysis of 662 Cases of Cognitive Damage

Abstract
Objective: To obtain and examine MedWatch reports of cases of cognitive impairment associated with Lipitor (atorvastatin).

Methods: FDA database MedWatch reports of atorvastatin-associated adverse events were searched for terms that included the word amnesia. This search revealed reports listed as transient amnesia, transient global amnesia, wandering amnesia, anterograde amnesia, dissociative amnesia, and retrograde amnesia. No reports were uncovered using the terms memory loss, memory disturbance, or memory disruption; yet memory impairment revealed multiple reports. Searches were directed at only serious cognitive events. Minor events such as forgetfulness or confusion were not sought, and it is possible that we missed an occasional serious event listed under a mild symptom. The well-known Naranjo ADR Probability Scale was applied to 50 randomly selected case reports of Lipitor-associated cognitive dysfunction.

Results: Six hundred and sixty-two MedWatch reports were received of atorvastatin-associated cognitive impairments. Of these, 399 were cases of amnesia, and 263 were cases of memory impairment. The number of reports per year increased from 1997 through 2006. Random analysis of individual MedWatch reports demonstrated that most were definitely or probably caused by atorvastatin. The average atorvastatin dosage of cases in 1997–2001 was 15 mg/day, whereas the average dosage in 2006 was 22 mg/day. Earlier research suggests that the number of MedWatch reports for statin-linked adverse events greatly underestimates the scope of the problem. Other research suggests that statin drugs may cause subclinical yet important cognitive impairments in all patients receiving statins.

Conclusion: The findings of the present study, coupled with earlier research, demonstrate the urgent need for further research regarding the frequency and severity of cognitive impairments in patients receiving statin drugs. (more…)